Tune Therapeutics

Seattle, Washington, USA and Durham, North Carolina, USA

Tune Therapeutics develops TEMPO, an epigenomic platform that fine-tunes gene activity without altering DNA. It is developing therapies for chronic hepatitis B, rare single-gene disorders and other conditions.

Facts

HQ
Seattle, Washington, USA and Durham, North Carolina, USA
Sectors
Biotechnology, Therapeutics, Epigenomics
Stage
Series B
Members see funding amounts.
.

Is this your organization? Claim it

Members see Tune Therapeutics's funding rounds, amounts and investors.